Renovorx Stock Today
| RNXT Stock | USD 0.99 0.03 2.94% |
PerformanceVery Weak
| Odds Of DistressVery High
|
RenovoRx is selling for under 0.99 as of the 16th of March 2025; that is 2.94 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.96. RenovoRx has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California. Renovorx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 35.57 M outstanding shares of which 205.91 K shares are at this time shorted by private and institutional investors with about 1.12 trading days to cover. More on RenovoRx
Moving against RenovoRx Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
RenovoRx Stock Highlights
| Secretary CEO | Shaun Bagai |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
RenovoRx (RNXT) is traded on NASDAQ Exchange in USA. It is located in 4546 El Camino Real, Los Altos, CA, United States, 94022 and employs 8 people. RenovoRx is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.06 M. RenovoRx conducts business under Biotechnology sector and is part of Health Care industry. The entity has 35.57 M outstanding shares of which 205.91 K shares are at this time shorted by private and institutional investors with about 1.12 trading days to cover.
RenovoRx currently holds about 10.77 M in cash with (10.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check RenovoRx Probability Of Bankruptcy
Ownership AllocationRenovoRx owns a total of 35.57 Million outstanding shares. Roughly 95.87 pct. of RenovoRx outstanding shares are held by general public with 1.28 % owned by insiders and only 2.85 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check RenovoRx Ownership Details
RenovoRx Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. RenovoRx market risk premium is the additional return an investor will receive from holding RenovoRx long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | 0.3656 | |||
| Treynor Ratio | (0.24) |
RenovoRx Stock Against Markets
RenovoRx Corporate Management
| Ronald CPA | VP Controller | Profile | |
| James Ahlers | Chief Officer | Profile | |
| Leesa Gentry | Senior Operations | Profile | |
| Angela Nelms | Chief Officer | Profile | |
| Ryan Witt | Senior Partnerships | Profile | |
| Robert Strasser | Vice RD | Profile | |
| Ramtin MD | Chairman Founder | Profile |
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.